Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
The flaw that landed Sanofi a win in the rare disease space
Europe
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen.   4 September 2025
Roche resolves cancer test dispute with Stanford affiliated startup
Americas
The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims.   4 September 2025
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
Americas
The company’s decision to sue US customs may result in a “roadmap” to sidestep ITC orders—and patent litigators are watching, finds Marisa Woutersen.   3 September 2025
Europe
Carpmaels & Ransford appoints two litigation partners as the UK firm expands its presence in Germany in response to UPC demand.   3 September 2025
Europe
A High Court decision clarifies how cross-undertakings work in patent disputes, rejecting claims for exceptional remedies beyond compensation.   2 September 2025
Americas
Non-practising entities are controversial, but political winds in the US are shifting and inventors, investors, and operating companies of all stripes should take note, writes Manny Caixeiro of Venable.   1 September 2025
Europe
A rare “innovator v innovator” case puts Pfizer in the firing line over its COVID-19 drug, highlighting the Unified Patent Court as an attractive forum for ‘David vs Goliath’ scenarios, say experts.   29 August 2025
Europe
A high number of filings from China has driven patent applications up by nearly a third at Ireland’s intellectual property office, which also reported a rise in SPC applications and strong activity in the medtech sector.   28 August 2025
Americas
Natus Medical retaliates against startup’s complaint in a patent clash over wearable diagnostic and monitoring products for neurological conditions.   27 August 2025
Europe
The executive chair of Beck Greener enabled a smaller firm to swerve private equity and join its stable—a move that boosts what was already a "clear path to growth" under his bold leadership, discovers Sarah Speight.   26 August 2025